Research Library

In this commentary, the authors examine the roots of the United States’ reluctance to embrace universal health care, concluding that it "is neither sound nor ethical in a nation that promulgates fairness and equal opportunity" to deny coverage.

Nonresident fellow Gary Hale, former chief of intelligence in the Houston Field Division of the Drug Enforcement Administration, pulls no punches in a blog on the escape of Mexican drug lord Chapo Guzman.

How will Mexico's government and military respond in the long run to the humiliating escape of Chapo Guzman, the country's most powerful drug trafficker?

Asthma in children costs an estimated $27 billion annually for doctor visits, emergency department visits and hospitalizations. Not surprisingly, kids with asthma miss more days of school and do worse academically. The first step to the management and treatment of asthma is access to a primary care provider who can prescribe the necessary medications and develop an asthma action plan. However, if we want to have a significant impact on the negative consequences of this disease on our children, a multi-faceted approach that includes policy is an absolute must.

If past trends hold for Annise Parker’s successor, this fall Houstonians may well be in actuality electing the person who will guide the city until January 2022.

After more than half a century of a highly restrictive policy toward Cuba that ranged from an economic embargo to prohibiting most travel by U.S. citizens to the island, President Obama announced on Dec. 17, 2014, that Washington and Havana hope to restore diplomatic relations in the near future. While President Obama's new Cuba policy falls short of lifting the embargo, which can only be done through congressional action, it nonetheless represents a historic shift in U.S. relations and leadership in Latin America.

Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”